Strategic financial planning and contract management with pharmaceutical.• Financial responsibility for strategic and tactical operational planning for all clinical studies budgets. • Monthly/annual accountability for budgets and variance analysis including responsibility for all forecasting and reporting.• Direct and primary responsibility for management of all contracts for all outsourced clinical studies.• Responsible for negotiating all Institutional/Investigator contracts within specified financial parameters and legal constraints while substantiating Fair Market Value.• Develop and implement strategic long-term relationships with CROs/vendors to optimize value in R&D spent utilizing performance based agreements.• Responsible for developing and consolidating all-inclusive project budgets and measuring established control KPIs against industry benchmarks.• Financial liaison to Global Project Teams including cross-functional budget management. • Part of management core team establishing policy, SOPs and continuous process improvement.

• Pro-active in developing strategic financial plan with hands-on budgeting and monitoring performance. • Financial implementation of product launch processes, interfacing with co-promotional alliance partner. Forecasted product life-cycle business analysis calculating metrics including eROI. • Operational planning and set-up of ‘best practices’ within GAAP regulations during merger

Planning, budgeting and analysis of $200 million BU within Global Medical Affairs.• Financial responsibility for Global Medical Affairs Group achieving target goals within 3% of budget. Key contributor to Therapeutic Medical Affairs Teams within Evidence Based Medicine. • Concentrated emphasis on planning, forecasting and cost management, supporting the budget details to over 180 Global Clinical Trials (including Oncology budgets) conducted in 23 different affiliates.• Financial director to Strategic Global Savings Team, achieving 77% of aggressive corporate-wide target in renegotiating major CRO/Outsourcing contracts in post-merger re-organization.• Re-deployed Corporate Financial Policy issues as “workable best practices” within the Global Medical Affairs group bringing clarity to concepts such as inter-company-margins, Global Clinical Study consolidations, FTE costing & forecasting, CRO contract management and supply-chain efficiency. • Developed strategy and implemented methodology for consolidating global clinical trial costs in eRoom, eliminating duplication and gaining cooperative support from affiliates.